Adrenomedullin (University of Miyazaki)

重组人肾上腺髓质素(宫崎大学)

Report date: 2026/02/09 20:01:27

Base Information

Drug NameAdrenomedullin (University of Miyazaki)
Drug Alias NameRecombinant long-acting human adrenomedullin (h-AM)1-52aa coupled to PEG-5000PEG5000-h.AM (1-52)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAdrenomedullin receptor agonists
TargetsAdrenomedullin receptor
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Miyazaki
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Miyazaki
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A